In this continuation of a three-part series, the author explores the potential use of agentic AI in pharmaceutical R&D.

Agentic AI enables autonomous coordination of AI agents, offering potential for process reinvention in life sciences beyond ...

Every drug cartel needs someone to do the money laundering. The perfectly legal drug industry known as Big Pharma channels its vast profits through the equally respectable industry we might call Big ...

Bengaluru: Govt and private quota seats for D-Pharma course will be allotted on merit through counselling conducted by Karnataka Examinations Authority (KEA) from academic year 2025-26, the govt said ...

Over the past two years, the pharmaceutical industry has quietly waged a massive lobbying campaign to try to block proposed EU regulations for the sector. Big pharma companies have invested particular ...

Recent studies have highlighted increasing biomedical innovation originating from Asia—especially China—over the past decade 1. Research and development (R&D) partnerships and licensing transactions ...

India’s ₹5,000-cr plan opens applications to fund pharma and medtech R&D, helping firms move beyond low-cost generics toward ...

It's hard to keep up with modern business, a reality spectacularly proven by the company we have under the microscope today, Allergan. It was once a US-quoted pharma group domiciled in Ireland (with a ...

Ascendis Pharma A/S (NASDAQ:ASND) shareholders will have a reason to smile today, with the analysts making substantial upgrades to this year's statutory forecasts. The revenue forecast for this year ...